lmdit cw1 nowotwory piersi 2
TRANSCRIPT
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
1/14
Breast tissue diagnosis by
Raman spectroscopyB. Broek-Puska*, J.Surmacki*, J. Jaboska**, R. Kordek**,
H. Abramczyk*
*Laboratory of Laser Molecular Spectroscopy,
Institute of Applied Radiation Chemistry,
Technical University of d, Faculty of Chemistry, Poland
**Department of Oncology, Medical University of d, Poland
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
2/14
GOAL
Some substances are produced by the organism in response to the
cancers presence. They are called tumor markers.
Tumor markers are molecules occurring in blood or tissue that are
associated with cancer and whose measurement or identification is useful in
patient diagnosis or clinical management. The ideal marker would be a
blood test for cancer in which a positive result would occur only in
patients with malignancy, one that would correlate with stage and response
to treatment and that was easily and reproducibly measured. No tumor
marker now available has met this ideal.
We believe that optical methods including Raman spectroscopy will provide such
a marker. Possibly it will help to find the hallmarks of cancer.
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
3/14
immediate in vivo diagnosis
reduction the number of biopsies
combination of biochemical and histopathological
diagnosis provides more information because pathology
is intimately related to biochemistry
method has a potential to remove human interpretation
non-invasive,non-ionizing method that probes with
chemical specificity vibrations and fluorescence (not just
structure) extremaly high spatial resolution (optical imaging)
Why ?
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
4/14
Human speciemens obtained from surgery. Upon
removal during the operation, the ex vivo sample is
devided by a doctor into two parts, one goes to our lab
the second goes to the pathology examination
The ex vivo samples are neither frozen in liquidnitrogen for storage nor fixed in formalin, the fresh
tissue is measured immeditely after delivering from
the hospital
The samples for pathology measurements are
passively thawed at room temperature and kept
moist with PBS fixed in formalin
Cut through the marked locations into 5-m-thicksections, and stained with eosin
normal tissue
0
5000
0
5000
8000
6000
4000
2000
0
0 500 1000 1500 2000 2500 3000 3500 4000
5000
10000
15000
20000
25000
30000
35000
514nm, normal tissue
25mW
100mW
Intensity
(arbitrary
units)
Raman shift in wavennumbers [cm-1
]
0 5 00 1 00 0 1 50 0 2 00 0 2 50 0 3 00 0 3 50 0 4 00 0
12000
14000
16000
18000
20000
22000
24000
26000
514nm, 100mW, cancer
Inten
sity
(arbitrary
units)
Raman shift in wavennumbers [cm-1]
0
10000
20000
0
10000
20000
20000
15000
10000
5000
0
maligant tissue
Tissue Preparation
carcinoma mammae fibroadenoma mammae
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
5/14
Measurements Parameters
The laser excitation is 514 nm, the spot is d=500 m in diameter
Light diffusion in the tissue results in a spot of v1mm
Integration time 0.5 s
Spectral resolution 2 and 8 cm -1
The laser excitation power: 25 mW, 100mW
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
6/14
Patients Statistics
1100 spectra from 100 patients
fibroadenomas
infiltrating carcinoma
infiltrating ductal carcinoma (IDC)
infiltrating lobular carcinoma (ILC)
IDC+ILC
multifocal carcinoma
carcinoma microinvasive
intracystic papillary carcinoma (noninvasive)
carcinoma mucinosumcarcinoma intraductal microinvasive
benign dysplasia
dysplasia benign dysplasia (cystes, apocrinal metaplasia,adenosis)
ductal-lobular hyperplasia
cystic mastopathy
0 1000 2000 3000 4000 5000 6000 7000 80000
1000
2000
3000
40000014 KT - normal tissue
25mW
514 541 572 607 647 691 743 802 872 [nm]
relative wavenumber [cm-1]
Intensity
[counts/s]
0 1000 2000 3000 4000 5000 6000 7000 80000
1000
2000
3000
40000014 KT - carcinoma lobulare infiltrans mammae
25mW
514 541 572 607 647 691 743 802 872 [nm]
relative wavenumber [cm-1]
Intensity
[counts/s]
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
7/14
Comparison between the Raman spectra for normal and
malignant tissue (infiltrating ductal carcinoma (IDC))
0 1000 2000 3000 4000 5000 6000 7000 80000
2500
5000
7500
10000
12500
15000
25mW
0006 KT - normal tissue
514 541 572 607 647 691 743 802 872 [nm]
relative wavenumber [cm-1]
Intensity
[counts/s]
0 1000 2000 3000 4000 5000 6000 7000 80000
2500
5000
7500
10000
12500
15000
25mW
0006 KT - carcinoma ductale infiltrans G2
514 541 572 607 647 691 743 802 872 [nm]
relative wavenumber [cm-1]
Intensity
[counts/s]
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
8/14
Quenching of autofluorescence by low temperature Raman
spectroscopy
0 5 00 1 00 0 1 50 0 2 000 2 50 0 3 000 3 50 0 4 00 0
-500
0
500
1000
1500
2000
2500
normal tissue - patient nr 90
intensity
(cts/s)
wavenumber (cm-1)
K90T33 - 250K
K90T34 - 200K
K90T35 - 170K
K90T36 - 150K
K90T37 - 110K
K90T38 - 77K
0 500 1000 1500 2000 2500 3000 3500 4000
-100
0
100
200
300
400
500
600
cancer tissue - patient nr 90
intensity
9cts/s)
wavenumber (cm-1)
K90T14 - 250K
K90T15 - 200K
K90T16 - 170K
K90T17 - 150K
K90T18 - 110K
K90T19 - 77K
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
9/14
Comparison between the Raman spectra for normal and
malignant tissue (carcinoma mucinosum )
0 2000 4000 6000 8000
-500
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
Y
AxisTitle
X Axis Title
K14T2 (carcinoma mucinosum mammae sinistri)K14T2 (normal tissue)
wavenumber [1/cm]
intensity
[cts/s]
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
10/14
Comparison between the Raman spectra for normal and benign
tumour tissue (fibroadenoma)
0 2000 4000 6000 8000
0
200
400
600
800
1000
1200
1400
1600
1800
YA
xisTitle
X Axis Title
K31T5 (normal tissue)
K31T8 (Fibroadenoma mamae)
wavenumber [1/cm]
intensity
[cts/s]
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
11/14
PRINCIPAL COMPONENT ANALYSIS (PCA)PLS_Toolbox Version 4.0
for use with MATLAB
Barry M. WiseNeal B. GallagherRasmus BroJeremy M. Shaver
Willem WindigR. Scott Koch
Eigenvector Research, Inc.3905 West Eaglerock Drive
Wenatchee, WA 98801
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
12/14
1
PCA score plot mean center, SNV, 1-st derivative
-1 -0.5 0 0.5 1 1.5 2-1.4
-1.2
-1
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
Scores on PC 1 (66.25%)
ScoresonPC2(7
.70%)
cc
hc
hhh
h
h
c
c h
c
c
c
h
h
c
h
h
hh
hw
w
h
hc h
ccc h
c
c
c hc
c
c
hw
ww
w
w
h
w
www
hww w
hh
hcc c h
c
cc
h
Samples/Scores Plot of HY
Decluttered
10
20
30
40
50
60
No Raman peaks Intensive Raman peaks
Normal tissue
Malignant tissue
High autofluorescence
Low autofluorescence
Benign
tissue
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
13/14
500 1000 1500 2000 2500 3000 3500-0.2
-0.15
-0.1
-0.05
0
0.05
0.1
0.15
0.2
wavenumber (cm-1)
Load
ingsonPC1(66.2
5%)
Variables/Loadings Plot for HY
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
C-H
streching
lipids
C-C and
C=C
stretching
carotenoids
PCA loading plot mean center, SNV, 1-st derivative
-
8/13/2019 LMDiT Cw1 Nowotwory Piersi 2
14/14
CONCLUSIONS
The results clearly illustrates the ability of Raman
spectroscopy to accurately diagnose breast cancer anddemonstrates how the diagnostic scheme can be adjusted toobtain the desired degree of sensitivity and specificity(88%,72%)
The normal tissue has a characteristic bands: C-C (1110 cm-1)and C=C (1520 cm-1) stretching bands of carotenoids and at
2840-2900 cm-1 for the C-H symmetric and asymmetric bands oflipids (fat) which are not visible in the malignant tissue and inbenign tumor tissue. Moreover, the fluorescence is much higherin the malignant tissue.
We belive that in a very near future a good quality Raman
signal will be obtained with the optical fibers coupled with abiopsy needle and incorporated into Raman spectrometer forbreast tissue measurements in vivo.